期刊
ANNUAL REVIEW OF MEDICINE
卷 60, 期 -, 页码 293-306出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev.med.60.062107.090340
关键词
chronic eosinophilic leukemia; eosinophil-associated gastrointestinal disorders; Churg-Strauss vasculitis; episodic angioedema and eosinophilia; chronic eosinophilic pneumonia; familial eosinophilia
资金
- National Institutes of Health
- NIAID
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000805, ZIAAI000805] Funding Source: NIH RePORTER
Hypereosinophilic syndrome is a heterogeneous group of rare disorders characterized by marked blood or tissue eosinophilia resulting in a wide variety of clinical manifestations. Although the existence of clinical subtypes (or variants) of HES has been appreciated for some time, the recent characterization of some of these variants at the molecular and immunologic levels has demonstrated dramatic differences in disease pathogenesis, response to treatment, and prognosis depending oil the etiology of the eosinophilia. This, together with the availability of novel targeted therapies, including tyrosine kinase inhibitors and monoclonal antibodies, has fundamentally altered the approach to the diagnosis and treatment of HES.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据